These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 15673502)

  • 41. Outbreak of Clostridium difficile-associated disease in a small animal veterinary teaching hospital.
    Weese JS; Armstrong J
    J Vet Intern Med; 2003; 17(6):813-6. PubMed ID: 14658717
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clostridium difficile Infection and Patient-Specific Antimicrobial Resistance Testing Reveals a High Metronidazole Resistance Rate.
    Barkin JA; Sussman DA; Fifadara N; Barkin JS
    Dig Dis Sci; 2017 Apr; 62(4):1035-1042. PubMed ID: 28116592
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Epidemiology of suspected Clostridium difficile-associated hospital-acquired diarrhea in hospitalized patients at Siriraj Hospital.
    Thipmontree W; Kiratisin P; Manatsathit S; Thamlikitkul V
    J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S207-16. PubMed ID: 21721449
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Clostridium difficile associated diarrhea in the elderly patient].
    Pareja Sierra T; Hornillos Calvo M
    Rev Clin Esp; 2007 Feb; 207(2):86-90. PubMed ID: 17397570
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Therapy for Clostridium difficile infection - any news beyond Metronidazole and Vancomycin?
    Manthey CF; Eckmann L; Fuhrmann V
    Expert Rev Clin Pharmacol; 2017 Nov; 10(11):1239-1250. PubMed ID: 28766951
    [TBL] [Abstract][Full Text] [Related]  

  • 46. E test susceptibility testing of nosocomial Clostridium difficile isolates against metronidazole, vancomycin, fusidic acid and the novel agents moxifloxacin, gatifloxacin, and linezolid.
    Leroi MJ; Siarakas S; Gottlieb T
    Eur J Clin Microbiol Infect Dis; 2002 Jan; 21(1):72-4. PubMed ID: 11913510
    [No Abstract]   [Full Text] [Related]  

  • 47. Emphysematous cystitis due to recurrent Clostridium difficile infection.
    van Genderen ME; Jonkman JG; van Rijn M; Dees A
    BMJ Case Rep; 2014 Dec; 2014():. PubMed ID: 25519862
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of Clostridium difficile-associated diarrhea.
    Malnick SD; Zimhony O
    Ann Pharmacother; 2002 Nov; 36(11):1767-75. PubMed ID: 12398575
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical impact of Clostridium difficile colonization.
    Hung YP; Lee JC; Lin HJ; Liu HC; Wu YH; Tsai PJ; Ko WC
    J Microbiol Immunol Infect; 2015 Jun; 48(3):241-8. PubMed ID: 24890755
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Management of an outbreak of Clostridium difficile-associated disease among geriatric patients.
    Cherifi S; Delmee M; Van Broeck J; Beyer I; Byl B; Mascart G
    Infect Control Hosp Epidemiol; 2006 Nov; 27(11):1200-5. PubMed ID: 17080377
    [TBL] [Abstract][Full Text] [Related]  

  • 51. C-reactive protein is a useful predictor of metronidazole treatment failure in mild-to-moderate Clostridium difficile infection.
    Farne HA; Martin NK; Main J; Orchard T; Tyrrell-Price J
    Eur J Gastroenterol Hepatol; 2013 Jan; 25(1):33-6. PubMed ID: 23026925
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Control of nosocomial Clostridium difficile transmission in bone marrow transplant patients.
    Hanna H; Raad I; Gonzalez V; Umphrey J; Tarrand J; Neumann J; Champlin R
    Infect Control Hosp Epidemiol; 2000 Mar; 21(3):226-8. PubMed ID: 10738997
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Therapeutic approaches for Clostridium difficile infections.
    Marsh JW; Curry SR
    Curr Protoc Microbiol; 2013 Oct; 30():9A.3.1-9A.3.9. PubMed ID: 24510892
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Past, present, and future therapies for Clostridium difficile-associated disease.
    Surowiec D; Kuyumjian AG; Wynd MA; Cicogna CE
    Ann Pharmacother; 2006 Dec; 40(12):2155-63. PubMed ID: 17148650
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Risk of Clostridium difficile infection in intensive care unit patients with sepsis exposed to metronidazole.
    Sabbah MA; Schorr C; Czosnowski QA; Hunter K; Torjman MC; Fraimow HS; Zanotti S; Tsigrelis C
    Infect Dis (Lond); 2015 Apr; 47(4):197-202. PubMed ID: 25622943
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clostridium difficile infection: new insights into management.
    Khanna S; Pardi DS
    Mayo Clin Proc; 2012 Nov; 87(11):1106-17. PubMed ID: 23127735
    [TBL] [Abstract][Full Text] [Related]  

  • 57. "Diversion" colitis caused by Clostridium difficile infection: report of a case.
    Tsironi E; Irving PM; Feakins RM; Rampton DS
    Dis Colon Rectum; 2006 Jul; 49(7):1074-7. PubMed ID: 16729217
    [TBL] [Abstract][Full Text] [Related]  

  • 58. New drugs and strategies for management of Clostridium difficile colitis.
    Higa JT; Kelly CP
    J Intensive Care Med; 2014; 29(4):190-9. PubMed ID: 23753229
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Non-conventional antimicrobial and alternative therapies for the treatment of Clostridium difficile infection.
    Roshan N; Hammer KA; Riley TV
    Anaerobe; 2018 Feb; 49():103-111. PubMed ID: 29309845
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Recurrences in Clostridium difficile infections in cancer patients].
    García-Lozano T; Aznar-Oroval E; Martín-Utrilla S
    Med Clin (Barc); 2016 Nov; 147(9):417-418. PubMed ID: 27293195
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.